Horizon is a global biopharmaceutical company focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our portfolio, along with our pipeline, is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We are relentless in pursuing breakthroughs that boldly change the lives of the communities we serve. Discover more about our medicines in rheumatology, including the first and only biologic treatment for uncontrolled gout, and research for new therapeutic targets in gout and systemic sclerosis at www.HorizonTherapeutics.com.